{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Metro", "lead_paragraph": "A proposed alliance between Continuum Health Partners and NYU Langone Medical Center reflects a wider trend toward bigger medical organizations.", "headline": {"seo": "N.Y.C. Hospital Groups, Continuum and NYU, May Ally", "main": "Two Major Hospital Groups in City Explore a Partnership", "print_headline": "Two Major Hospital Groups In City Explore a Partnership"}, "abstract": "Continuum Health Partners and NYU Langone Medical Center, two of New York City's major hospital organizations, are exploring a partnership that would give them a large share of the city's patients and make them a formidable rival for other city hospitals in tough economic times.", "print_page": "32", "word_count": "833", "_id": "515b90cffdc59278db00ca82", "snippet": "A proposed alliance between Continuum Health Partners and NYU Langone Medical Center reflects a wider trend toward bigger medical organizations.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/10/21/nyregion/nyc-hospital-groups-continuum-and-nyu-may-ally.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Continuum Health Partners", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "New York University Langone Medical Center", "is_major": "Y", "rank": "2", "name": "organizations"}, {"value": "Hospitals", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Reform and Reorganization", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "New York City", "is_major": "N", "rank": "6", "name": "glocations"}, {"value": "Mergers, Acquisitions and Divestitures", "is_major": "Y", "rank": "7", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Anemona", "lastname": "HARTOCOLLIS"}], "original": "By ANEMONA HARTOCOLLIS"}, "document_type": "article", "pub_date": "2011-10-21T00:00:00Z", "section_name": "N.Y. / Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "A GlaxoSmithKline vaccine now in clinical trials protected nearly half of the children who received it from bouts of serious malaria, researchers reported.", "headline": {"seo": "Glaxo\u2019s RTS,S Malaria Vaccine Shows Promise, Scientists Say", "main": "Scientists See Promise in Vaccine for Malaria", "print_headline": "Scientists See Promise In Vaccine For Malaria"}, "abstract": "Research published in New England Journal of Medicine reports that GlaxoSmithKline malaria vaccine now in clinical trials protected nearly half of the children who received it from serious bouts of illness.", "print_page": "4", "word_count": "601", "_id": "515b91b6fdc59278db00cb97", "snippet": "A GlaxoSmithKline vaccine now in clinical trials protected nearly half of the children who received it from bouts of serious malaria, researchers reported.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/10/19/health/19malaria.html", "multimedia": [{"subtype": "xlarge", "url": "images/2011/10/19/health/19malaria/19malaria-articleLarge.jpg", "height": 398, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2011/10/19/health/19malaria/19malaria-articleLarge.jpg", "xlargeheight": "398"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2011/10/19/health/19malaria/19malaria-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2011/10/19/health/19malaria/19malaria-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Malaria", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Vaccination and Immunization", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Babies and Infants", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "GlaxoSmithKline PLC", "is_major": "Y", "rank": "5", "name": "organizations"}, {"value": "New England Journal of Medicine", "is_major": "Y", "rank": "6", "name": "organizations"}], "byline": {"contributor": "", "person": [{"qualifier": "Jr", "firstname": "Donald", "middlename": "G.", "lastname": "McNEIL", "rank": 1, "role": "reported", "organization": ""}], "original": "By DONALD G. McNEIL Jr"}, "document_type": "article", "pub_date": "2011-10-19T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "An unexpected finding: A bacterium never particularly prevalent in the colon seems to have an affinity for colon cancers.", "headline": {"seo": "Separate Cancer Studies, but a Single Suspicion of Bacteria", "main": "Two Cancer Studies Find Bacterial Clue in Colon", "print_headline": "Two Cancer Studies Find Bacterial Clue in Colon"}, "abstract": "Separate studies led by Dr Robert A Holt and Dr Matthew Meyerson find link between Fusobacterium, bacterium that is not particularly prevalent in colon, and colon cancer; studies are published together online in journal Genome Research.", "print_page": "1", "word_count": "1007", "_id": "515b91ecfdc59278db00cbd9", "snippet": "An unexpected finding: A bacterium never particularly prevalent in the colon seems to have an affinity for colon cancers.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/10/18/health/18cancer.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Colon and Colorectal Cancer", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Research", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Genetics and Heredity", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Bacteria", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Genome Research (Journal)", "is_major": "Y", "rank": "6", "name": "organizations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "2011-10-18T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "In \u201cThe Origins of AIDS,\u201d Dr. Jacques P\u00e9pin starts from 1900 to work out the most likely path the virus took during the years it left almost no tracks.", "headline": {"seo": "Chimp to Human to History Books: The Circuitous Path of AIDS", "main": "Chimp to Man to History Books: The Path of AIDS", "print_headline": "Chimp to Human To History Books: The Path of AIDS"}, "abstract": "Infectious disease specialist Dr Jacques Pepin attempts to trace AIDS virus to its earliest beginnings, decades before it was noticed, in new book The Origin of AIDS.", "print_page": "1", "word_count": "2137", "_id": "515a8ce5fdc59278db00546e", "snippet": "In \u201cThe Origins of AIDS,\u201d Dr. Jacques P\u00e9pin starts from 1900 to work out the most likely path the virus took during the years it left almost no tracks.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/10/18/health/18aids.html", "multimedia": [{"subtype": "thumbnail", "url": "images/2011/10/18/science/18JPAIDS3/18JPAIDS3-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2011/10/18/science/18JPAIDS3/18JPAIDS3-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Acquired Immune Deficiency Syndrome", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Monkeys and Apes", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Pepin, Jacques", "is_major": "Y", "rank": "5", "name": "persons"}, {"value": "Books and Literature", "is_major": "Y", "rank": "6", "name": "subject"}], "byline": {"contributor": "", "person": [{"qualifier": "Jr", "firstname": "Donald", "middlename": "G.", "lastname": "McNEIL", "rank": 1, "role": "reported", "organization": ""}], "original": "By DONALD G. McNEIL Jr"}, "document_type": "article", "pub_date": "2011-10-18T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The new test may reduce the need for riskier invasive procedures like amniocentesis, but it raises ethical issues.", "headline": {"seo": "Sequenom&#8217;s Test for Down Syndrome Raises Hopes and Questions", "main": "A Less Risky Down Syndrome Test Is Developed", "print_headline": "A Less Risky Down Test Lifts Hopes"}, "abstract": "New test to detect Down syndrome in a fetus using a sample of the mother's blood may reduce the need for riskier invasive procedures like amniocentesis; researchers say tests may not be reliable enough yet to replace traditional testing, but may reduce the need for such procedures; there is some concern that test could lead more women to end pregnancies, causing a decline in the number of people with the condition and leading to diminished support for them.", "print_page": "1", "word_count": "1310", "_id": "515b9215fdc59278db00cc08", "snippet": "The new test may reduce the need for riskier invasive procedures like amniocentesis, but it raises ethical issues.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/10/18/business/sequenom-test-for-down-syndrome-raises-hopes-and-questions.html", "multimedia": [{"width": 75, "url": "images/2011/10/18/business/Down/Down-thumbStandard.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2011/10/18/business/Down/Down-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "Y", "value": "Tests (Medical)", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Down Syndrome", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Genetics and Heredity", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Amniocentesis", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "firstname": "Andrew", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2011-10-18T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Letters", "lead_paragraph": "Readers respond to an article about states adding drug tests as a hurdle for welfare.", "headline": {"main": "Testing State Aid Recipients for Drugs", "kicker": "Letters", "print_headline": "Testing State Aid Recipients for Drugs", "content_kicker": "Letters"}, "abstract": "Letters from Director Paul N Samuels of the Legal Action Center, Dr Robert L DuPont, founding director of the National Institute on Drug Abuse and Susan E Foster, director at the National Center on Addiction and Substance Abuse at Columbia University, comment on Oct 11 front page article about states adding drug tests to list of requirements for welfare eligibility.", "print_page": "18", "word_count": "660", "_id": "515b92c2fdc59278db00ccca", "snippet": "Readers respond to an article about states adding drug tests as a hurdle for welfare.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/10/15/opinion/testing-state-aid-recipients-for-drugs.html", "multimedia": [{"subtype": "wide", "url": "images/2011/10/15/opinion/15LETTERS/15LETTERS-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2011/10/15/opinion/15LETTERS/15LETTERS-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2011/10/15/opinion/15LETTERS/15LETTERS-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2011/10/15/opinion/15LETTERS/15LETTERS-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Welfare (US)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Tests (Drug Use)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Drug Abuse and Traffic", "is_major": "Y", "rank": "3", "name": "subject"}], "byline": [], "document_type": "article", "pub_date": "2011-10-15T00:00:00Z", "section_name": "Opinion"}], "meta": {"hits": 6, "offset": 0, "time": 42}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}